NK510

· Base Therapeutics (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NK510, covering 2025-09-10 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NK510 to Treat NSCLC [EARLY_Phase 1]